Although in the 39 eligible and assessable ES patients no associations with outcome were found, there was an association between low VEGF-A concentrations and improved overall survival, and between high sMET concentrations and improved PFS among the 42 eligible and assessable OS patients. Here, VEGFA is linked to Ewing sarcoma.